BIOMAT Database Logo BIOMAT Database Logo

Embryotoxicity of L-prolyl-L-leucyl-glycinamide, cyclo(1-amino-cyclopentanecarbonyl-alanyl) and cyclo(glycyl-leucyl), new potential neuropeptides in chick embryos. 1988

K Kosar, and J Vanzura
Department of Pharmacological Propaedeutics and Organic Chemistry, Faculty of Pharmacy, Charles University, Hradec Králové, Czechoslovakia.

With the use of the method Chick Embryotoxicity Screening Test II (CHEST II), the potential neuropeptides L-prolyl-L-leucyl-glycinamide (MIF), cyclo(1-aminocyclo-pentanecarbonyl-L-alanyl)[cyclo(Acp-Ala)] and cyclo(glycyl-L-leucyl)[Cyclo(Gly-Leu)] were tested in the critical developmental periods of d 1.5 to 4 of chick embryogenesis in order to objectively examine their undesirable interactions with the developing morphogenetic systems of the brain, eye, face, body wall, limbs, trunk and heart. All compounds tested showed positive dose- and stage-response relationships. The body wall defects are the prevailing type of malformations.

UI MeSH Term Description Entries
D009075 MSH Release-Inhibiting Hormone A hypothalamic tripeptide, enzymatic degradation product of OXYTOCIN, that inhibits the release of MELANOCYTE-STIMULATING HORMONES. MSH Release-Inhibiting Factor,Melanocyte-Stimulating Hormone Release-Inhibiting Hormone,Prolyl-Leucyl-Glycinamide,H-Pro-Leu-Gly-NH2,MIF-1,MIF-I,Melanocyte-Stimulating Hormone Release-Inhibiting Factor,Melanostatin,Oxytocin (7-9),Pro-Leu-Gly-NH2,Pro-Leu-Glyamide,Prol-Leu-Gly-NH2,Prolylleucylglycinamide,Prol Leu Gly NH2,Prolyl Leucyl Glycinamide
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D000014 Abnormalities, Drug-Induced Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. Drug-Induced Abnormalities,Abnormalities, Drug Induced,Abnormality, Drug-Induced,Drug Induced Abnormalities,Drug-Induced Abnormality
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

K Kosar, and J Vanzura
Conformation of cyclic dipeptides. Ab initio calculations on cyclo (glycyl-glycyl), cyclo (D-alanyl-L-alanyl), and cyclo (L-alanyl-L-alanyl).
November 1976, Biopolymers,
K Kosar, and J Vanzura
L-prolyl-L-leucyl-glycinamide analogues--a new class of peptide antihypertensives.
December 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
K Kosar, and J Vanzura
Conformation of cyclic octapeptides. VI. Structure of cyclo-bis-(-L-alanyl-glycyl-L-prolyl-L-phenylalanyl-) tetrahydrate.
July 1991, Acta crystallographica. Section C, Crystal structure communications,
K Kosar, and J Vanzura
Pharmacology of L-prolyl-L-leucyl-glycinamide (PLG): a review.
January 1983, Methods and findings in experimental and clinical pharmacology,
K Kosar, and J Vanzura
Carbon-13 NMR spectra of cyclo-glycyl-L-prolyl-glycyl-glycyl-L-prolyl-glycyl: assignment of the carbonyl resonances.
February 1973, FEBS letters,
K Kosar, and J Vanzura
Studies of peptide antibiotics. XV. The synthesis of cyclo-(1-valyl-1-ornithyl-1-leucyl-d-phenylalanyl-1-prolyl-glycyl-glycyl).
January 1970, Bulletin of the Chemical Society of Japan,
K Kosar, and J Vanzura
Memory enhancement induced in chicks by L-prolyl-L-leucyl-glycinamide.
November 1982, Pharmacology, biochemistry, and behavior,
K Kosar, and J Vanzura
Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide.
January 1979, European journal of pharmacology,
K Kosar, and J Vanzura
Synthesis and structural studies of two collagen analogues: poly (L-prolyl-L-seryl-glycyl) and poly (L-prolyl-L-alanyl-glycyl).
January 1972, Journal of molecular biology,
K Kosar, and J Vanzura
[Mechanism of PLG (L-prolyl-L-leucyl-glycinamide) in treating Parkinson's disease].
August 1985, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
Copied contents to your clipboard!